A Phase II Study of Dacomitinib in Progressive Brain Metastases
Status:
Terminated
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the disease response, survival, and side effects of
an experimental drug called dacomitinib in progressive brain metastases.